Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Letters in Functional Foods
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2666-9390
  • E-ISSN: 2666-9404

Abstract

Excessive alcohol consumption over time is one of the primary causes of liver disease and death globally. Because there is no effective treatment, the situation has become more complicated, and the emphasis has shifted to the use of alternative and complementary medicine to treat liver problems. Herbs with dietary use have played an important part in the treatment of liver diseases since antiquity. Amla or Indian gooseberry, scientifically known as or , is a fruiting plant of the Phyllanthaceae family that is used in a variety of traditional and folk medical systems. The fruits have both dietary and medicinal value and are used to prevent chemical-induced hepatocarcinogenesis and reduce experimentally induced hyperlipidemia and metabolic syndrome in laboratory animals. They also have hepatoprotective effects against a variety of hepatotoxins such as heavy metals, iron overload, ochratoxins, hexachlorocyclohexane, carbon tetrachloride, therapeutic drugs such as paracetamol, and antitubercular. Amla fruits and phytochemicals such as quercetin, gallic acid, ellagic acid, and kaempferol are known to reduce ethanol-induced liver damage, and mechanistic studies have shown that the beneficial effects of these phytochemicals are mediated in part by free radical scavenging, antioxidant, and anti-inflammatory effects. This review examines the positive effects of amla fruit and its phytochemicals for the first time, as well as the mechanisms underlying the protective effects.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/lff/10.2174/0126669390257953231101111549
2024-01-22
2024-11-22

  • From This Site

    /content/journals/lff/10.2174/0126669390257953231101111549
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. GhanyM.G. HoofnagleJ.H. Approach to the Patient with Liver Disease.Harrison’s Principles of Internal Medicine, 20e.New York, NYMcGraw-Hill Education2018
     [Google Scholar]
  2. ShivashankaraA.R. AzmidahA. HaniadkaR. RaiM.P. AroraR. BaligaM.S. Dietary agents in the prevention of alcohol-induced hepatotoxicty: Preclinical observations.Food Funct.20123210110910.1039/C1FO10170F 22119904
     [Google Scholar]
  3. SaberiB. DadabhaiA.S. JangY.Y. GurakarA. MezeyE. Current Management of Alcoholic Hepatitis and Future Therapies.J. Clin. Transl. Hepatol.201642113122 27350941
     [Google Scholar]
  4. AlbillosA. de GottardiA. RescignoM. The gut-liver axis in liver disease: Pathophysiological basis for therapy.J. Hepatol.202072355857710.1016/j.jhep.2019.10.003 31622696
     [Google Scholar]
  5. SzaboG. PetrasekJ. Gut–liver axis and sterile signals in the development of alcoholic liver disease.Alcohol Alcohol.201752441442410.1093/alcalc/agx025 28482064
     [Google Scholar]
  6. SubramaniyanV. ChakravarthiS. JegasothyR. Alcohol-associated liver disease: A review on its pathophysiology, diagnosis and drug therapy.Toxicol. Rep.2021837638510.1016/j.toxrep.2021.02.010 33680863
     [Google Scholar]
  7. GuoF.F. XiaoM. WangS.Y. ZengT. ChengL. XieQ. Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver.Toxicol. Mech. Methods202030640741610.1080/15376516.2020.1747126 32237978
     [Google Scholar]
  8. WenB. ZhangC. ZhouJ. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways.Pharmacol. Ther.202122210775210.1016/j.pharmthera.2020.107752 33253739
     [Google Scholar]
  9. YouM. JogasuriaA. LeeK. Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.Curr. Mol. Pharmacol.201710322623610.2174/1874467208666150817112109 26278388
     [Google Scholar]
  10. ThilakchandK.R. MathaiR.T. SimonP. RaviR.T. Baliga-RaoM.P. BaligaM.S. Hepatoprotective properties of the Indian gooseberry (Emblica officinalis Gaertn): A review.Food Funct.20134101431144110.1039/c3fo60237k 23978895
     [Google Scholar]
  11. BaligaM.S. DsouzaJ.J. Amla (Emblica officinalis Gaertn), a wonder berry in the treatment and prevention of cancer.Eur. J. Cancer Prev.201120322523910.1097/CEJ.0b013e32834473f4 21317655
     [Google Scholar]
  12. GulatiR.K. AgarwalS. AgrawalS.S. Hepatoprotective studies on Phyllanthus emblica Linn. and quercetin.Indian J. Exp. Biol.1995334261268 7558182
     [Google Scholar]
  13. ReddyV.D. PadmavathiP. VaradacharyuluN.C. Emblica officinalis protects against alcohol-induced liver mitochondrial dysfunction in rats.J. Med. Food200912232733310.1089/jmf.2007.0694 19459733
     [Google Scholar]
  14. PramyothinP. SamosornP. PoungshompooS. ChaichantipyuthC. The protective effects of Phyllanthus emblica Linn. extract on ethanol induced rat hepatic injury.J. Ethnopharmacol.2006107336136410.1016/j.jep.2006.03.035 16750340
     [Google Scholar]
  15. YaoP. NusslerA. LiuL. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways.J. Hepatol.200747225326110.1016/j.jhep.2007.02.008 17433488
     [Google Scholar]
  16. LiuS. HouW. YaoP. Quercetin protects against ethanol-induced oxidative damage in rat primary hepatocytes.Toxicol. In Vitro 201024251652210.1016/j.tiv.2009.03.006 19327393
     [Google Scholar]
  17. ChenX. Protective effects of quercetin on liver injury induced by ethanol.Pharmacogn. Mag.201062213514110.4103/0973‑1296.62900 20668581
     [Google Scholar]
  18. MolinaM.F. Sanchez-ReusI. IglesiasI. BenediJ. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver.Biol. Pharm. Bull.200326101398140210.1248/bpb.26.1398 14519943
     [Google Scholar]
  19. TangY. GaoC. XingM. Quercetin prevents ethanol-induced dyslipidemia and mitochondrial oxidative damage.Food Chem. Toxicol.20125051194120010.1016/j.fct.2012.02.008 22365892
     [Google Scholar]
  20. TangY. LiY. YuH. Quercetin attenuates chronic ethanol hepatotoxicity: Implication of “free” iron uptake and release.Food Chem. Toxicol.20146713113810.1016/j.fct.2014.02.022 24569067
     [Google Scholar]
  21. LiY. ChenM. XuY. Iron-Mediated Lysosomal Membrane Permeabilization in Ethanol-Induced Hepatic Oxidative Damage and Apoptosis: Protective Effects of Quercetin.Oxid. Med. Cell. Longev.2016201611510.1155/2016/4147610 27057276
     [Google Scholar]
  22. ZhuM. ZhouX. ZhaoJ. Quercetin prevents alcohol induced liver injury through targeting of PI3K/Akt/nuclear factor κB and STAT3 signaling pathway.Exp. Ther. Med.20171466169617510.3892/etm.2017.5329 29285175
     [Google Scholar]
  23. KartkayaK. OğlakçıA. ŞentürkH. BayramoğluG. CanbekM. KanbakG. Investigation of the possible protective role of gallic acid on paraoxanase and arylesterase activities in livers of rats with acute alcohol intoxication.Cell Biochem. Funct.201331320821310.1002/cbf.2874 22945768
     [Google Scholar]
  24. ZhouY. JinH. WuY. ChenL. BaoX. LuC. Gallic acid protects against ethanol-induced hepatocyte necroptosis via an NRF2-dependent mechanism.Toxicol. In Vitro 20195722623210.1016/j.tiv.2019.03.008 30853489
     [Google Scholar]
  25. DevipriyaN. SudheerA.R. VishwanathanP. MenonV.P. Modulatory potential of ellagic acid, a natural plant polyphenol on altered lipid profile and lipid peroxidation status during alcohol-induced toxicity: A pathohistological study.J. Biochem. Mol. Toxicol.200822210111210.1002/jbt.20226 18418896
     [Google Scholar]
  26. DevipriyaN. SudheerA.R. MenonV.P. Dose-response effect of ellagic acid on circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats.Fundam. Clin. Pharmacol.200721662163010.1111/j.1472‑8206.2007.00551.x 18034663
     [Google Scholar]
  27. DevipriyaN. SudheerA.R. SrinivasanM. MenonV.P. Effect of Ellagic Acid, a Plant Polyphenol, on Fibrotic Markers (MMPs and TIMPs) during Alcohol-Induced Hepatotoxicity.Toxicol. Mech. Methods200717634935610.1080/15376510601077003 20020958
     [Google Scholar]
  28. GirishC. PradhanS.C. Drug development for liver diseases: Focus on picroliv, ellagic acid and curcumin.Fundam. Clin. Pharmacol.200822662363210.1111/j.1472‑8206.2008.00618.x 19049667
     [Google Scholar]
  29. SohnE.H. KooH.J. HangD.T.T. Protective effects of ellagic acid on ethanol-induced toxicity in hepatic HepG2 cells.Mol. Cell. Toxicol.20139324925610.1007/s13273‑013‑0032‑1
     [Google Scholar]
  30. Calderón-MontañoJ.M. Burgos-MorónE. Pérez-GuerreroC. López-LázaroM. A review on the dietary flavonoid kaempferol.Mini Rev. Med. Chem.201111429834410.2174/138955711795305335 21428901
     [Google Scholar]
  31. ShakyaG. ManjiniS. HodaM. RajagopalanR. Hepatoprotective role of kaempferol during alcohol- and ΔPUFA-induced oxidative stress.J. Basic Clin. Physiol. Pharmacol.2014251737910.1515/jbcpp‑2013‑0051 23893680
     [Google Scholar]
  32. ZhouB. JiangZ. LiX. ZhangX. Kaempferol’s Protective Effect on Ethanol-Induced Mouse Primary Hepatocytes Injury Involved in the Synchronous Inhibition of SP1, Hsp70 and CYP2E1.Am. J. Chin. Med.20184651093111010.1142/S0192415X1850057X 29976085
     [Google Scholar]
  33. ChenJ. XuanY. LuoM. Kaempferol alleviates acute alcoholic liver injury in mice by regulating intestinal tight junction proteins and butyrate receptors and transporters.Toxicology202042915233810.1016/j.tox.2019.152338 31785310
     [Google Scholar]
  34. SairamK. RaoChV. BabuM.D. KumarK.V. AgrawalV.K. K GoelR.K. Antiulcerogenic effect of methanolic extract of Emblica officinalis: An experimental study.J. Ethnopharmacol.20028211910.1016/S0378‑8741(02)00041‑7 12169398
     [Google Scholar]
  35. Al-RehailyA.J. Al-HowirinyT.S. Al-SohaibaniM.O. RafatullahS. Gastroprotective effects of ‘Amla’ Emblica officinalis on in vivo test models in rats.Phytomedicine20029651552210.1078/09447110260573146 12403160
     [Google Scholar]
  36. ArunaR. GeethaA. SugunaP. SuganyaV. Rutin rich Emblica officinalis Geart. fruit extract ameliorates inflammation in the pancreas of rats subjected to alcohol and cerulein administration.J. Complement. Integr. Med.201411191810.1515/jcim‑2013‑0023 24516008
     [Google Scholar]
  37. AntoE.J. SyahputraR.A. SilitongaH.A. SitumorangP.C. NugarahaS.E. Oral acute toxicity study extract ethanol of balakka fruit (Phyllanthus emblica).Pharmacia202269118719410.3897/pharmacia.69.e81280
     [Google Scholar]
  38. AntonyB. BennyM. KaimalT.N.B. A Pilot clinical study to evaluate the effect of Emblica officinalis extract (Amlamax™) on markers of systemic inflammation and dyslipidemia.Indian J. Clin. Biochem.200823437838110.1007/s12291‑008‑0083‑6 23105791
     [Google Scholar]
  39. ChenT.S. LiouS.Y. ChangY.L. Supplementation of Emblica officinalis (Amla) extract reduces oxidative stress in uremic patients.Am. J. Chin. Med.2009371192510.1142/S0192415X09006680 19222108
     [Google Scholar]
  40. Karkon VarnosfaderaniS. Hashem-DabaghianF. AminG. Efficacy and safety of Amla (Phyllanthus emblica L.) in non-erosive reflux disease: A double-blind, randomized, placebo-controlled clinical trial.J. Integr. Med.201816212613110.1016/j.joim.2018.02.008 29526236
     [Google Scholar]
  41. KhannaS. DasA. SpieldennerJ. RinkC. RoyS. Supplementation of a standardized extract from Phyllanthus emblica improves cardiovascular risk factors and platelet aggregation in overweight/class-1 obese adults.J. Med. Food201518441542010.1089/jmf.2014.0178 25756303
     [Google Scholar]
  42. PingaliU. FatimaN. PilliR. Evaluation of Phyllanthus emblica extract on cold pressor induced cardiovascular changes in healthy human subjects.Pharmacognosy Res.201461293510.4103/0974‑8490.122914 24497739
     [Google Scholar]
  43. AkhtarM.S. RamzanA. AliA. AhmadM. Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients.Int. J. Food Sci. Nutr.201162660961610.3109/09637486.2011.560565 21495900
     [Google Scholar]
  44. KapoorM.P. SuzukiK. DerekT. OzekiM. OkuboT. Clinical evaluation of Emblica officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.Contemp. Clin. Trials Commun.20201710049910.1016/j.conctc.2019.100499 31890983
     [Google Scholar]
  45. UsharaniP. MeruguP.L. NutalapatiC. Evaluation of the effects of a standardized aqueous extract of Phyllanthus emblica fruits on endothelial dysfunction, oxidative stress, systemic inflammation and lipid profile in subjects with metabolic syndrome: A randomised, double blind, placebo controlled clinical study.BMC Complement Med Ther2019199710.1186/s12906‑019‑2509‑5
     [Google Scholar]
  46. UpadyaH. PrabhuS. PrasadA. SubramanianD. GuptaS. GoelA. A randomized, double blind, placebo controlled, multicenter clinical trial to assess the efficacy and safety of Emblica officinalis extract in patients with dyslipidemia.BMC Complement. Altern. Med.20191912710.1186/s12906‑019‑2430‑y 30670010
     [Google Scholar]
/content/journals/lff/10.2174/0126669390257953231101111549
Loading

  • Article Type:     Review Article
Keyword(s): alcohol; Emblica officinalis; hepatotoxicity; hyperlipidemia; Indian gooseberry; Phyllanthus emblica

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test